For this first human study of luseogliflozin , randomized , single-blind , placebo-controlled , single ascending dose ( @-@mg ) and multiple ascending dose ( @ or @mg/day , @days ) trials were conducted in healthy male Japanese subjects to investigate safety , pharmacokinetics , and pharmacodynamics .